It is estimated that by the year 2030, there will be 8.6 million adults with diabetes in Egypt, making it the country with the tenth largest population of diabetics in the world [1]. The prevalence of diabetes rises dramatically with age in both sexes; it reaches almost 20% among females aged 50-59 [2]. The burden of diabetes in adults is often described in terms of its impact on working-age, while in older adults it is linked to decreased functional status, institutionalization, and mortality [3]. Older persons and/or those with multiple comorbidities have often been excluded from randomized controlled trials of treatment despite having the highest prevalence of diabetes [4].